BioRad.io

Discover how multimodal and longitudinal data are transforming drug discovery and personalized medicine. Alessandro Riccombeni, CEO of Axia Medicine, discusses health AI, interoperability, clinical trials, and the future of connected health data.

Learn how AI can help you manage complex biological data in biopharma. Explore strategies for better software, databases, and data standardization to stay compliant, enable innovation, and build a strong foundation for AI-driven drug discovery.

Explore how AI is transforming drug discovery. Learn how generative and agentic AI, data integration, and workflow optimization can accelerate research, overcome challenges, and drive collaboration in pharmaceutical R&D.

Discover the future lab, an ecosystem where digital transformations shape the landscape of biopharma research, driving innovation and unlocking the potential of tomorrow's therapies.

Data silos and challenges around data fragmentation and interoperability hinder holistic insights and innovation in R&D. Employing strategy around the patient at the center of data interoperability can provide accelerated insights and innovation through a unified approach to data management.

Historically, cancer drug development has a high failure rate. Why is that, and how can we facilitate success? Listen in as we chat with the co-founder of a company that is trying to shift the paradigm using AI and machine learning.